15,031
edits
Helminthic therapy and COVID-19: Difference between revisions
Helminthic therapy and COVID-19 (view source)
Revision as of 17:55, 15 November 2022
, 15 November 2022→The emerging science
| Line 16: | Line 16: | ||
== The emerging science == | == The emerging science == | ||
* 2022 Nov 10 [https://www.biorxiv.org/content/10.1101/2022.11.09.515832v1?fbclid=IwAR3Vz7tzTRlqlJBbBgHuogDe0CFqFguZqfjZZfAiZJclXWdP9KzGBE5VKxY Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation] -- [https://www.biorxiv.org/content/10.1101/2022.11.09.515832v1.full Full text] | [https://www.biorxiv.org/content/10.1101/2022.11.09.515832v1.full.pdf PDF] | |||
::This study shows that lung remodelling from a prior helminth infection promotes recovery and less severe outcomes in mice challenged with SARS-CoV-2. | |||
* 2022 Jun 28 [https://pubmed.ncbi.nlm.nih.gov/35764965/ Helminth antigens differentially modulate the activation of CD4 + and CD8 + T lymphocytes of convalescent COVID-19 patients in vitro] | * 2022 Jun 28 [https://pubmed.ncbi.nlm.nih.gov/35764965/ Helminth antigens differentially modulate the activation of CD4 + and CD8 + T lymphocytes of convalescent COVID-19 patients in vitro] | ||